Cardiograft®
Video: Cardiovascular Facility Tour
Bio-Implants for Cardiac Procedures
Aortic Heart Valve
Download a PDF| Cryopreserved | | Description | | Sizing |
|---|
| HVAS | | Aortic Heart Valve | | D = 16 mm and less |
| HVAM | | Aortic Heart Valve | | D = 17 - 21 mm |
| HVAL | | Aortic Heart Valve | | D = 22 mm and greater |
| Freeze-dried | | Description | | Sizing |
|---|
| OCELL100 | | | | |
Clinical Application
- Left side/aortic reconstructions
- Aortic stenosis/atresia
- Hypoplastic left heart
- Repair of RVOTs (Right Ventricular Outflow Tract)
Features and Benefits
- No anticoagulation therapy required
- Exceptionally good hemodynamic performance
- No immunosuppressive therapy needed
- Non-thrombogenic
- Non-hemolytic
- Human tissue - most closely resembles native tissue
- High resistance to infection
Ascending Aorta (non-valved)
Download a PDF| Cryopreserved | | Description | | Sizing |
|---|
| AAS | | Ascending Aorta (non-valved) | | D = 16 mm and less |
| AAM | | Ascending Aorta (non-valved) | | D = 17 - 21 mm |
| AAL | | Ascending Aorta (non-valved) | | D = 22 mm and greater |
Clinical Application
Features and Benefits
- Non-thrombogenic
- Non-hemolytic
- No immunosuppressive therapy required
- Human tissue - most closely resembles native tissue
- High resistance to infection
- No anticoagulation therapy required
Hemi-Pulmonary Artery
Download a PDF| Cryopreserved | | Description | | Sizing |
|---|
| RHPA | | Right Hemi-Pulmonary Artery | | Varies |
| LHPA | | Left Hemi-Pulmonary Artery | | Varies |
Clinical Application
- Tetralogy of Fallot
- Pulmonary atresia
- Single ventricle/double outlet (Fontan)
- Truncus arteriosus
- Transposition of great vessels
- Hypoplastic left heart (modified Fontan)
- Aortic stenosis/atresia
Features and Benefits
- No Anticoagulation therapy required
- Non-thrombogenic
- Non-hemolytic
- No immunosuppressive therapy required
- Human tissue - most closely resembles native tissue
- High resistance to infection
Mono Cusp Patch
Download a PDF| Cryopreserved | | Description | | Sizing |
|---|
| RMCP | | Right Mono Cusp Patch | | W/L Varies |
| LMCP | | Left Mono Cusp Patch | | W/L Varies |
| MCP | | Mono Cusp Patch | | 1.0 cm or greater of conduit to the distal commissure |
Clinical Application
- Tetralogy of Fallot
- RVOT/root enlargement procedures
Features and Benefits
- Single valved section of main pulmonary trunk
- Original annulus diameter
- Length and width measured in centimeters
- No minimum or maximum width
Pulmonary Artery (non-valved)
Download a PDF| Cryopreserved | | Description | | Sizing |
|---|
| PAS | | Pulmonary Artery (non-valved) | | D = 16 mm and less |
| PAM | | Pulmonary Artery (non-valved) | | D = 17 - 21 mm |
| PAL | | Pulmonary Artery (non-valved) | | D = 22 mm and greater |
Clinical Application
- Right side/pulmonary reconstructions
- Tetralogy of Fallot
- Pulmonary atresia
- Single ventricle/double outlet (Fontan)
- Truncus arteriosus
- Pulmonary root stenosis
Features and Benefits
- No Anticoagulation therapy required
- Non-thrombogenic
- Non-hemolytic
- No immunosuppressive therapy required
- Human tissue - most closely resembles native tissue
- High resistance to infection
Pulmonary Heart Valve
Download a PDF| Cryopreserved | | Description | | Sizing |
|---|
| HVPS | | Pulmonary Heart Valve | | D = 16 mm and less |
| HVPM | | Pulmonary Heart Valve | | D = 17 - 21 mm |
| HVPL | | Pulmonary Heart Valve | | D = 22 mm and greater |
Clinical Application
- Right side/pulmonary reconstructions
- Hypoplastic left heart (modified Fontan)
- Ross procedure
- Truncus arteriosus
- Pulmonary atresia
- Single ventricle/double outlet (Fontan)
- Pulmonary root stenosis
Features and Benefits
- No Anticoagulation therapy required
- Non-thrombogenic
- Non-hemolytic
- No immunosuppressive therapy required
- Human tissue - most closely resembles native tissue
- High resistance to infection
Thoracic Aorta
Download a PDF| Cryopreserved | | Description | | Sizing |
|---|
| TAS | | Thoracic Aorta | | D = 16 mm and less |
| TAM | | Thoracic Aorta | | D = 17 – 21 mm |
| TAL | | Thoracic Aorta | | D = 22 mm and greater |
Clinical Application
- Infected descending aorta
- Conduit repair
- Extra-cardiac shunt
Features and Benefits
- No Anticoagulation therapy required
- Non-thrombogenic
- Non-hemolytic
- No immunosuppressive therapy required
- Human tissue - most closely resembles native tissue
- High resistance to infection
Pulmonary Patch
Download a PDFDescription
Pulmonary patch section produced from the main pulmonary artery.
| Cryopreserved | | Description | | Sizing |
|---|
| PPGN | | Thin Pulmonary Patch | | W = 2 - 5 cm L=3 - 8 cm |
| PPGK | | Thick Pulmonary Patch | | W = 2 - 5 cm L=3 - 8 cm |
Clinical Application
- Right side/pulmonary reconstructions
- Tralogy of Fallot
- Single ventricle/double outlet (Fontan)
- Truncus arterious; ASD/VSD repair
Features and Benefits
- No anticoagulation therapy required
- Non-thromogenic
- Non-hemolytic
- No immunosuppressive therapy requiredHuman tissue - most closely resembles native tissue
- High resistance to infection
Decellularized Pulmonary Patch
Download a PDFDescription
Decellularized pulmonary patch with Matracell™.
| Cryopreserved | | Description | | Sizing |
|---|
| DPPGN | | Thin Pulmonary Patch (decellularized) | | W = 2 - 5 cm L=3 - 8 cm |
| DPPGK | | Thick Pulmonary Patch (decellularized) | | W = 2 - 5 cm L=3 - 8 cm |
Features and Benefits
Matracell™ safely removes donor cells and DNA without sacrificing the biomechanical strength of the allograft bio-implant.
Decellularized Hemi-Pulmonary Artery
Download a PDFDescription
Decellularized Hemi-Pulmonary Artery with Matracell™
| Frozen | | Description | | Sizing |
|---|
| DRHPA | | Right Hemi-Pulmonary Artery (decellularized) | | Right |
| DLHPA | | Left Hemi-Pulmonary Artery (decellularized) | | Left |